Overview
Christopher Kelsey is a Radiation Oncologist in Durham, North Carolina. Dr. Kelsey and is rated as an Advanced provider by MediFind in the treatment of Anaplastic Large Cell Lymphoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Kelsey is currently accepting new patients.
His clinical research consists of co-authoring 34 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Cigna
- Blue Cross Blue Shield
- Friday Health
- AmeriHealth
- Piedmont
Locations
40 Duke Medicine Cir, Durham, NC 27710
2351 Erwin Rd, Durham, NC 27705
2301 Erwin Rd, Durham, NC 27705
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung Cancer
- Follicular Lymphoma
- Large-Cell Lung Carcinoma
- Lung Adenocarcinoma
- Lung Cancer
- Advanced
- Anaplastic Large Cell Lymphoma
- Classical Hodgkin Lymphoma
- Cutaneous T-Cell Lymphoma (CTCL)
- Hodgkin Lymphoma
- Lymphomatoid Papulosis
- Mesothelioma
- Experienced
- Familial Prostate Cancer
- Lung Nodules
- Mediastinal Tumor
- Melanoma
- Myeloproliferative Neoplasms (MPN)
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)